Loading viewer...
earnings
Format: PDF earnings
Karyopharm Therapeutics presented second quarter 2022 financial results and business updates on August 4, 2022, featuring commercial highlights for XPOVIO and pipeline developments for selinexor and eltanexor. The presentation includes financial guidance, drug development updates, and forward-looking statements regarding commercialization efforts in multiple myeloma and diffuse large B-cell lymphoma.
conference
34 Pages
earnings
20 Pages
bpost
Bank of Georgia Group 1Q22 Performance Investor Presentation
earningsearnings
70 Pages
Bank of Georgia Group
Toro Company Q3 2023 Earnings Release
earningsearnings
27 Pages
The Toro Company